Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

This development underscores India's commitment to supporting the Global South with affordable healthcare solutions and adds ...

Earlier this year, the FDA approved 2 new indications for Aquaflor. According to Merck, the supplemental approval increased ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

A conversation with a medical doctor last week re-kindled a debate that refuses to die down. At a dinner party the doctor argued that patented drugs are better than generics. This sounded patently off ...

In a recent discussion with Dr. Joe Dituri on Power Athlete Radio, we explored the significant risk posed by America’s dependence on foreign-made pharmaceutical ...

Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency ...

R.I. Attorney General Peter Neronha joined a national coalition of attorneys last week announcing a $49.1 million settlement ...